IL6 and metabolic syndrome: TNF-α and IL-6-mediated dyslipidemia, indicated by elevated TG, low HDL, and high oxidized LDL, fosters a pro-atherogenic environment by promoting endothelial dysfunction and foam cell formation, ultimately accelerating the development and progression of atherosclerotic plaques as observed in our study as well.